Stockreport

Prelude Therapeutics To Participate in Barclays Global Healthcare Conference

Prelude Therapeutics Incorporated  (PRLD) 
PDF WILMINGTON, Del., March 01, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced [Read more]